{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:16:48Z","timestamp":1792783008902,"version":"4.5.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82371043"],"award-info":[{"award-number":["No. 82371043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Project of Outstanding Talents in Scientific and Technological Innovation and Entrepreneurship for Middle-aged and Young Scientists of Jilin Provincial Science and Technology Department","award":["No.20240601014RC"],"award-info":[{"award-number":["No.20240601014RC"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03876-w","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:11:18Z","timestamp":1765779078000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in the treatment of blinding retinal diseases"],"prefix":"10.1007","volume":"46","author":[{"given":"Zhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-1872","authenticated-orcid":false,"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"1","key":"3876_CR1","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13287-023-03564-5","volume":"14","author":"Y Liang","year":"2023","unstructured":"Liang Y, Sun X, Duan C, Tang S, Chen J (2023) Application of patient-derived induced pluripotent stem cells and organoids in inherited retinal diseases. Stem Cell Res Ther 14(1):340. https:\/\/doi.org\/10.1186\/s13287-023-03564-5","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3876_CR2","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/s2214-109x(20)30425-3","volume":"9","author":"R Bourne","year":"2021","unstructured":"Bourne R, Steinmetz JD, Flaxman S, Briant PS, Taylor HR, Resnikoff S, Casson RJ et al (2021) Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet Glob Health 9(2):e130\u2013e143. https:\/\/doi.org\/10.1016\/s2214-109x(20)30425-3","journal-title":"Lancet Glob Health"},{"issue":"2","key":"3876_CR3","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/s2214-109x(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2(2):e106-116. https:\/\/doi.org\/10.1016\/s2214-109x(13)70145-1","journal-title":"Lancet Glob Health"},{"issue":"2","key":"3876_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.survophthal.2024.11.010","volume":"70","author":"BB Rai","year":"2025","unstructured":"Rai BB, Maddess T, Nolan CJ (2025) Functional diabetic retinopathy: a new concept to improve management of diabetic retinal diseases. Surv Ophthalmol 70(2):232\u2013240. https:\/\/doi.org\/10.1016\/j.survophthal.2024.11.010","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"3876_CR5","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85(3):845\u2013881. https:\/\/doi.org\/10.1152\/physrev.00021.2004","journal-title":"Physiol Rev"},{"issue":"2","key":"3876_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.molmed.2015.12.007","volume":"22","author":"M Zarbin","year":"2016","unstructured":"Zarbin M (2016) Cell-based therapy for degenerative retinal disease. Trends Mol Med 22(2):115\u2013134","journal-title":"Trends Mol Med"},{"issue":"4","key":"3876_CR7","first-page":"431","volume":"56","author":"P Gouras","year":"1984","unstructured":"Gouras P, Flood MT, Kjeldbye H (1984) Transplantation of cultured human retinal cells to monkey retina. An Acad Bras Cienc 56(4):431\u2013443","journal-title":"An Acad Bras Cienc"},{"issue":"12","key":"3876_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/bf00184273","volume":"232","author":"PV Algvere","year":"1994","unstructured":"Algvere PV, Berglin L, Gouras P, Sheng Y (1994) Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 232(12):707\u2013716. https:\/\/doi.org\/10.1007\/bf00184273","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"3876_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/eer3.4","volume":"1","author":"J Xu","year":"2024","unstructured":"Xu J, Zhang CJ, Jiang JY, Jin ZB (2024) The next-generation therapies in ophthalmology for blindness worldwide. Eye & ENT Res 1(1):20\u201338","journal-title":"Eye & ENT Res"},{"issue":"9817","key":"3876_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/s0140-6736(12)60028-2","volume":"379","author":"SD Schwartz","year":"2012","unstructured":"Schwartz SD, Hubschman JP, Heilwell G, Franco-Cardenas V, Pan CK et al (2012) Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817):713\u2013720. https:\/\/doi.org\/10.1016\/s0140-6736(12)60028-2","journal-title":"Lancet"},{"issue":"11","key":"3876_CR11","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","volume":"376","author":"M Mandai","year":"2017","unstructured":"Mandai M, Watanabe A, Kurimoto Y, Hirami Y, Morinaga C et al (2017) Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration. N Engl J Med 376(11):1038\u20131046. https:\/\/doi.org\/10.1056\/NEJMoa1608368","journal-title":"N Engl J Med"},{"key":"3876_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072217","author":"S Sugita","year":"2020","unstructured":"Sugita S, Mandai M, Hirami Y, Takagi S, Maeda T et al (2020) HLA-Matched Allogeneic iPS Cells-Derived RPE Transplantation for Macular Degeneration. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9072217","journal-title":"J Clin Med"},{"issue":"5","key":"3876_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.molmed.2022.03.001","volume":"28","author":"T Maeda","year":"2022","unstructured":"Maeda T, Mandai M, Sugita S, Kime C, Takahashi M (2022) Strategies of pluripotent stem cell-based therapy for retinal degeneration: update and challenges. Trends Mol Med 28(5):388\u2013404. https:\/\/doi.org\/10.1016\/j.molmed.2022.03.001","journal-title":"Trends Mol Med"},{"issue":"2","key":"3876_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/hep.28459","volume":"64","author":"S Todo","year":"2016","unstructured":"Todo S, Yamashita K, Goto R, Zaitsu M, Nagatsu A et al (2016) A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology 64(2):632\u2013643. https:\/\/doi.org\/10.1002\/hep.28459","journal-title":"Hepatology"},{"issue":"12","key":"3876_CR15","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.stem.2023.11.004","volume":"30","author":"Y Hirami","year":"2023","unstructured":"Hirami Y, Mandai M, Sugita S, Maeda A, Maeda T et al (2023) Safety and stable survival of stem-cell-derived retinal organoid for 2 years in patients with retinitis pigmentosa. Cell Stem Cell 30(12):1585-1596.e1586. https:\/\/doi.org\/10.1016\/j.stem.2023.11.004","journal-title":"Cell Stem Cell"},{"issue":"1","key":"3876_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.5966\/sctm.2014-0205","volume":"4","author":"J Hsiung","year":"2015","unstructured":"Hsiung J, Zhu D, Hinton DR (2015) Polarized human embryonic stem cell-derived retinal pigment epithelial cell monolayers have higher resistance to oxidative stress-induced cell death than nonpolarized cultures. Stem Cells Transl Med 4(1):10\u201320. https:\/\/doi.org\/10.5966\/sctm.2014-0205","journal-title":"Stem Cells Transl Med"},{"issue":"6","key":"3876_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ophtha.2023.12.028","volume":"131","author":"MS Humayun","year":"2024","unstructured":"Humayun MS, Clegg DO, Dayan MS, Kashani AH, Rahhal FM et al (2024) Long-term Follow-up of a Phase 1\/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy. Ophthalmology 131(6):682\u2013691. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.028","journal-title":"Ophthalmology"},{"issue":"7","key":"3876_CR18","first-page":"865","volume":"61","author":"CD Riemann","year":"2020","unstructured":"Riemann CD, Banin E, Barak A, Boyer DS, Ehrlich R et al (2020) Phase I\/IIa clinical trial of human embryonic stem cell (hESC)-derived retinal pigmented epithelium (RPE, OpRegen) transplantation in advanced dry form age-related macular degeneration (AMD): interim results. Investig Ophthalmol Vis Sci 61(7):865\u2013865","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3876_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2022-000981","author":"E Daniele","year":"2022","unstructured":"Daniele E, Ferrari B, Rassu N, Ben-Nun J, Bosio L et al (2022) Comparison of human amniotic membrane decellularisation approaches for hESC-derived RPE cells culture. BMJ Open Ophthalmol. https:\/\/doi.org\/10.1136\/bmjophth-2022-000981","journal-title":"BMJ Open Ophthalmol"},{"issue":"3","key":"3876_CR20","doi-asserted-by":"publisher","DOI":"10.18063\/ijb.v8i3.550","volume":"8","author":"H Liu","year":"2022","unstructured":"Liu H, Wu F, Chen R, Chen Y, Yao K et al (2022) Electrohydrodynamic jet-printed ultrathin polycaprolactone scaffolds mimicking Bruch\u2019s membrane for retinal pigment epithelial tissue engineering. Int J Bioprint 8(3):550. https:\/\/doi.org\/10.18063\/ijb.v8i3.550","journal-title":"Int J Bioprint"},{"issue":"1","key":"3876_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13287-020-01608-8","volume":"11","author":"D Zhu","year":"2020","unstructured":"Zhu D, Xie M, Gademann F, Cao J, Wang P et al (2020) Protective effects of human iPS-derived retinal pigmented epithelial cells on retinal degenerative disease. Stem Cell Res Ther 11(1):98. https:\/\/doi.org\/10.1186\/s13287-020-01608-8","journal-title":"Stem Cell Res Ther"},{"key":"3876_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.reth.2023.12.016","volume":"25","author":"S Kitahata","year":"2024","unstructured":"Kitahata S, Mandai M, Ichikawa H, Tanaka Y, Senba T et al (2024) Investigation of the effectiveness of gelatin hydrolysate in human iPS-RPE cell suspension transplantation. Regen Ther 25:238\u2013249. https:\/\/doi.org\/10.1016\/j.reth.2023.12.016","journal-title":"Regen Ther"},{"issue":"10","key":"3876_CR23","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1016\/j.ymthe.2020.08.012","volume":"28","author":"D Meng","year":"2020","unstructured":"Meng D, Ragi SD, Tsang SH (2020) Therapy in rhodopsin-mediated autosomal dominant retinitis pigmentosa. Mol Ther 28(10):2139\u20132149. https:\/\/doi.org\/10.1016\/j.ymthe.2020.08.012","journal-title":"Mol Ther"},{"issue":"7785","key":"3876_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW et al (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576(7785):149\u2013157. https:\/\/doi.org\/10.1038\/s41586-019-1711-4","journal-title":"Nature"},{"issue":"1","key":"3876_CR25","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1038\/s41467-025-57628-6","volume":"16","author":"Y Fu","year":"2025","unstructured":"Fu Y, He X, Ma L, Gao XD, Liu P et al (2025) In vivo prime editing rescues photoreceptor degeneration in nonsense mutant retinitis pigmentosa. Nat Commun 16(1):2394. https:\/\/doi.org\/10.1038\/s41467-025-57628-6","journal-title":"Nat Commun"},{"key":"3876_CR26","doi-asserted-by":"crossref","unstructured":"Urnov FD (2024) Give Cas a chance: An actionable path to a platform for CRISPR cures. Mary Ann Liebert, Inc., publishers 140 Huguenot Street, 3rd Floor New.","DOI":"10.1089\/crispr.2024.0082"},{"key":"3876_CR27","doi-asserted-by":"crossref","unstructured":"Lek A, Wong B, Keeler A, Blackwood M, Ma K, et al. (2023) Unexpected Death of a Duchenne Muscular Dystrophy Patient in an N-of-1 Trial of rAAV9-delivered CRISPR-transactivator. MedRxiv: 2023.2005. 2016.23289881","DOI":"10.1101\/2023.05.16.23289881"},{"issue":"1","key":"3876_CR28","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","volume":"9","author":"JH Wang","year":"2024","unstructured":"Wang JH, Gessler DJ, Zhan W, Gallagher TL, Gao G (2024) Adeno-associated virus as a delivery vector for gene therapy of human diseases. Signal Transduct Target Ther 9(1):78. https:\/\/doi.org\/10.1038\/s41392-024-01780-w","journal-title":"Signal Transduct Target Ther"},{"key":"3876_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310524","author":"MV Ferreira","year":"2023","unstructured":"Ferreira MV, Fernandes S, Almeida AI, Neto S, Mendes JP et al (2023) Extending AAV packaging cargo through dual co-transduction: efficient protein trans-splicing at low vector doses. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241310524","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3876_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40291-024-00722-0","volume":"28","author":"ME McClements","year":"2024","unstructured":"McClements ME, Elsayed MEA, Major L, de la Camara CM-F, MacLaren RE (2024) Gene therapies in clinical development to treat retinal disorders. Mol Diagn Ther 28(5):575\u2013591","journal-title":"Mol Diagn Ther"},{"key":"3876_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100915","volume":"83","author":"K Bucher","year":"2021","unstructured":"Bucher K, Rodr\u00edguez-Bocanegra E, Dauletbekov D, Fischer MD (2021) Immune responses to retinal gene therapy using adeno-associated viral vectors - implications for treatment success and safety. Prog Retin Eye Res 83:100915. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100915","journal-title":"Prog Retin Eye Res"},{"key":"3876_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jconrel.2023.01.067","volume":"355","author":"L Kang","year":"2023","unstructured":"Kang L, Jin S, Wang J, Lv Z, Xin C et al (2023) AAV vectors applied to the treatment of CNS disorders: clinical status and challenges. J Control Release 355:458\u2013473. https:\/\/doi.org\/10.1016\/j.jconrel.2023.01.067","journal-title":"J Control Release"},{"key":"3876_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","volume":"303","author":"S Patel","year":"2019","unstructured":"Patel S, Ryals RC, Weller KK, Pennesi ME, Sahay G (2019) Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release 303:91\u2013100. https:\/\/doi.org\/10.1016\/j.jconrel.2019.04.015","journal-title":"J Control Release"},{"issue":"10","key":"3876_CR34","doi-asserted-by":"publisher","first-page":"eadl3576","DOI":"10.1126\/sciadv.adl3576","volume":"10","author":"J Shen","year":"2024","unstructured":"Shen J, Lima ESR, Zhang M, Luly KM, Hackett SF et al (2024) Suprachoroidal gene transfer with nonviral nanoparticles in large animal eyes. Sci Adv 10(10):eadl3576. https:\/\/doi.org\/10.1126\/sciadv.adl3576","journal-title":"Sci Adv"},{"key":"3876_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107335","volume":"208","author":"G Zhang","year":"2024","unstructured":"Zhang G, Wen X, Li Y, Sun J, Jia H et al (2024) Comprehensive assessment of the impact of intravitreal faricimab on retinal diseases: a systematic review, meta-analysis, and trial sequential analysis. Pharmacol Res 208:107335. https:\/\/doi.org\/10.1016\/j.phrs.2024.107335","journal-title":"Pharmacol Res"},{"key":"3876_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9945725","volume":"2021","author":"S Qin","year":"2021","unstructured":"Qin S, Dong N, Yang M, Wang J, Feng X et al (2021) Complement inhibitors in age-related macular degeneration: a potential therapeutic option. J Immunol Res 2021:9945725. https:\/\/doi.org\/10.1155\/2021\/9945725","journal-title":"J Immunol Res"},{"issue":"4","key":"3876_CR37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ophtha.2014.11.018","volume":"122","author":"MC Peden","year":"2015","unstructured":"Peden MC, Su\u00f1er IJ, Hammer ME, Grizzard WS (2015) Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degeneration. Ophthalmology 122(4):803\u2013808. https:\/\/doi.org\/10.1016\/j.ophtha.2014.11.018","journal-title":"Ophthalmology"},{"key":"3876_CR38","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.preteyeres.2015.09.003","volume":"50","author":"YH Luo","year":"2016","unstructured":"Luo YH, da Cruz L (2016) The Argus(\u00ae) II Retinal Prosthesis System. Prog Retin Eye Res 50:89\u2013107. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.09.003","journal-title":"Prog Retin Eye Res"},{"key":"3876_CR39","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041525","author":"D Palanker","year":"2023","unstructured":"Palanker D (2023) Electronic retinal prostheses. Cold Spring Harb Perspect Med. https:\/\/doi.org\/10.1101\/cshperspect.a041525","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3876_CR40","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.visres.2015.04.006","volume":"118","author":"ZM Hafed","year":"2016","unstructured":"Hafed ZM, Stingl K, Bartz-Schmidt KU, Gekeler F, Zrenner E (2016) Oculomotor behavior of blind patients seeing with a subretinal visual implant. Vision Res 118:119\u2013131. https:\/\/doi.org\/10.1016\/j.visres.2015.04.006","journal-title":"Vision Res"},{"issue":"5","key":"3876_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/ceo.13950","volume":"49","author":"PJ Allen","year":"2021","unstructured":"Allen PJ (2021) Retinal prostheses: where to from here? Clin Exp Ophthalmol 49(5):418\u2013429. https:\/\/doi.org\/10.1111\/ceo.13950","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"3876_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2024.100510","volume":"4","author":"MMK Muqit","year":"2024","unstructured":"Muqit MMK, Le Mer Y, de Olmos Koo L, Holz FG, Sahel JA et al (2024) Prosthetic visual acuity with the PRIMA subretinal microchip in patients with atrophic age-related macular degeneration at 4 years follow-up. Ophthalmol Sci 4(5):100510. https:\/\/doi.org\/10.1016\/j.xops.2024.100510","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"3876_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3928\/23258160-20160126-11","volume":"47","author":"DY Lee","year":"2016","unstructured":"Lee DY, Lorach H, Huie P, Palanker D (2016) Implantation of modular photovoltaic subretinal prosthesis. Ophthalmic Surg Lasers Imaging Retina 47(2):171\u2013174. https:\/\/doi.org\/10.3928\/23258160-20160126-11","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"3876_CR44","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41467-022-28125-x","volume":"13","author":"D Palanker","year":"2022","unstructured":"Palanker D, Le Mer Y, Mohand-Said S, Sahel JA (2022) Simultaneous perception of prosthetic and natural vision in AMD patients. Nat Commun 13(1):513. https:\/\/doi.org\/10.1038\/s41467-022-28125-x","journal-title":"Nat Commun"},{"key":"3876_CR45","unstructured":"Team S (2024) Science Announces Positive Preliminary Results For Vision Restoration In Pivotal Clinical Trial."},{"issue":"13","key":"3876_CR46","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.3390\/s23135782","volume":"23","author":"KY Wu","year":"2023","unstructured":"Wu KY, Mina M, Sahyoun J-Y, Kalevar A, Tran SD (2023) Retinal prostheses: engineering and clinical perspectives for vision restoration. Sensors 23(13):5782","journal-title":"Sensors"},{"issue":"5","key":"3876_CR47","doi-asserted-by":"publisher","first-page":"055008","DOI":"10.1088\/1741-2552\/ac8ed8","volume":"19","author":"ZC Chen","year":"2022","unstructured":"Chen ZC, Wang BY, Kochnev Goldstein A, Butt E, Mathieson K et al (2022) Photovoltaic implant simulator reveals resolution limits in subretinal prosthesis. J Neural Eng 19(5):055008. https:\/\/doi.org\/10.1088\/1741-2552\/ac8ed8","journal-title":"J Neural Eng"},{"issue":"7","key":"3876_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104539","volume":"25","author":"XS Zheng","year":"2022","unstructured":"Zheng XS, Yang Q, Vazquez A, Cui XT (2022) Imaging the stability of chronic electrical microstimulation using electrodes coated with PEDOT\/CNT and iridium oxide. iScience 25(7):104539. https:\/\/doi.org\/10.1016\/j.isci.2022.104539","journal-title":"iScience"},{"issue":"4","key":"3876_CR49","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41565-023-01570-5","volume":"19","author":"D Viana","year":"2024","unstructured":"Viana D, Walston ST, Masvidal-Codina E, Illa X, Rodr\u00edguez-Meana B et al (2024) Nanoporous graphene-based thin-film microelectrodes for in vivo high-resolution neural recording and stimulation. Nat Nanotechnol 19(4):514\u2013523. https:\/\/doi.org\/10.1038\/s41565-023-01570-5","journal-title":"Nat Nanotechnol"},{"key":"3876_CR50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.biomaterials.2016.10.018","volume":"112","author":"CG Eleftheriou","year":"2017","unstructured":"Eleftheriou CG, Zimmermann JB, Kjeldsen HD, David-Pur M, Hanein Y et al (2017) Carbon nanotube electrodes for retinal implants: a study of structural and functional integration over time. Biomaterials 112:108\u2013121. https:\/\/doi.org\/10.1016\/j.biomaterials.2016.10.018","journal-title":"Biomaterials"},{"key":"3876_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122674","volume":"311","author":"MB Bhuckory","year":"2024","unstructured":"Bhuckory MB, Wang BY, Chen ZC, Shin A, Pham-Howard D et al (2024) 3D electronic implants in subretinal space: long-term follow-up in rodents. Biomaterials 311:122674. https:\/\/doi.org\/10.1016\/j.biomaterials.2024.122674","journal-title":"Biomaterials"},{"issue":"6","key":"3876_CR52","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2552\/ab34b3","volume":"16","author":"E Ho","year":"2019","unstructured":"Ho E, Lei X, Flores T, Lorach H, Huang T et al (2019) Characteristics of prosthetic vision in rats with subretinal flat and pillar electrode arrays. J Neural Eng 16(6):066027. https:\/\/doi.org\/10.1088\/1741-2552\/ab34b3","journal-title":"J Neural Eng"},{"key":"3876_CR53","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2552\/ad2a37","author":"E Butt","year":"2024","unstructured":"Butt E, Wang BY, Shin A, Chen ZC, Bhuckory M et al (2024) Three-dimensional electro-neural interfaces electroplated on subretinal prostheses. J Neural Eng. https:\/\/doi.org\/10.1088\/1741-2552\/ad2a37","journal-title":"J Neural Eng"},{"issue":"1","key":"3876_CR54","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1038\/s41598-023-32976-9","volume":"13","author":"M Zhou","year":"2023","unstructured":"Zhou M, Young BK, Valle ED, Koo B, Kim J et al (2023) Full-field, conformal epiretinal electrode array using hydrogel and polymer hybrid technology. Sci Rep 13(1):6973. https:\/\/doi.org\/10.1038\/s41598-023-32976-9","journal-title":"Sci Rep"},{"key":"3876_CR55","doi-asserted-by":"publisher","DOI":"10.1088\/1741-2552\/abe6b8","author":"TW Huang","year":"2021","unstructured":"Huang TW, Kamins TI, Chen ZC, Wang BY, Bhuckory M et al (2021) Vertical-junction photodiodes for smaller pixels in retinal prostheses. J Neural Eng. https:\/\/doi.org\/10.1088\/1741-2552\/abe6b8","journal-title":"J Neural Eng"},{"issue":"1","key":"3876_CR56","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.1038\/s41467-022-34353-y","volume":"13","author":"BY Wang","year":"2022","unstructured":"Wang BY, Chen ZC, Bhuckory M, Huang T, Shin A et al (2022) Electronic photoreceptors enable prosthetic visual acuity matching the natural resolution in rats. Nat Commun 13(1):6627. https:\/\/doi.org\/10.1038\/s41467-022-34353-y","journal-title":"Nat Commun"},{"key":"3876_CR57","unstructured":"Luxa  (2025) Biotechnology presents data from phase 1\/2a clinical trial evaluating RPESC-RPE-4W."},{"issue":"7","key":"3876_CR58","first-page":"1862","volume":"63","author":"AC Ho","year":"2022","unstructured":"Ho AC, Banin E, Barak A, Boyer DS, Ehrlich R et al (2022) Safety and efficacy of a phase 1\/2a clinical trial of transplanted allogeneic retinal pigmented epithelium (RPE, OpRegen) cells in advanced dry age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 63(7):1862\u20131862","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9967","key":"3876_CR59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/s0140-6736(14)61376-3","volume":"385","author":"SD Schwartz","year":"2015","unstructured":"Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ et al (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: follow-up of two open-label phase 1\/2 studies. Lancet 385(9967):509\u2013516. https:\/\/doi.org\/10.1016\/s0140-6736(14)61376-3","journal-title":"Lancet"},{"issue":"8","key":"3876_CR60","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.ymthe.2021.04.024","volume":"29","author":"K Dulla","year":"2021","unstructured":"Dulla K, Slijkerman R, van Diepen HC, Albert S, Dona M et al (2021) Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations. Mol Ther 29(8):2441\u20132455. https:\/\/doi.org\/10.1016\/j.ymthe.2021.04.024","journal-title":"Mol Ther"},{"issue":"8","key":"3876_CR61","first-page":"5443","volume":"64","author":"DS Boyer","year":"2023","unstructured":"Boyer DS, Bergstrom L, Emanuelli A, Gonzalez VH, Wykoff CC et al (2023) Efficacy and safety of MCO-010 optogenetic therapy for vision restoration in patients with severe vision loss due to retinitis pigmentosa: a phase 2b randomized, sham-controlled, multi-center, multi-dose, double-masked clinical trial (RESTORE). Invest Ophthalmol Vis Sci 64(8):5443\u20135443","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3876_CR62","unstructured":"Ocugen, Inc (2025) Announces Positive 2-Year Data Across Multiple Mutations from Phase 1\/2 Clinical Trial of OCU400 \u2014A Novel Modifier Gene Therapy for Retinitis Pigmentosa."},{"issue":"7","key":"3876_CR63","first-page":"2134","volume":"65","author":"J-B Ducloyer","year":"2024","unstructured":"Ducloyer J-B, Le Meur G, Lebranchu P, Billaud F, Giraud L et al (2024) 12-Month safety and efficacy evaluation of HORA-PDE6B, a gene therapy targeting patients with retinitis pigmentosa due to biallelic PDE6B gene mutation. Invest Ophthalmol Vis Sci 65(7):2134\u20132134","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3876_CR64","first-page":"511","volume":"66","author":"W Zhou","year":"2025","unstructured":"Zhou W, Zhou M, Shirinzadeh M, Zhang H, Liu J et al (2025) Safety and efficacy of ZM-02 optogenetic gene therapy clinical study for advanced retinitis pigmentosa. Invest Ophthalmol Vis Sci 66(8):511\u2013511","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3876_CR65","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ajo.2024.11.021","volume":"271","author":"P Yang","year":"2025","unstructured":"Yang P, Birch D, Lauer A, Sisk R, Anand R et al (2025) Subretinal gene therapy drug AGTC-501 for XLRP phase 1\/2 multicenter study (HORIZON): 24-month safety and efficacy results. Am J Ophthalmol 271:268\u2013285. https:\/\/doi.org\/10.1016\/j.ajo.2024.11.021","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3876_CR66","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jamaophthalmol.2022.6254","volume":"141","author":"L von Krusenstiern","year":"2023","unstructured":"von Krusenstiern L, Liu J, Liao E, Gow JA, Chen G et al (2023) Changes in retinal sensitivity associated with cotoretigene toliparvovec in X-linked retinitis pigmentosa with RPGR gene variations. JAMA Ophthalmol 141(3):275\u2013283. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.6254","journal-title":"JAMA Ophthalmol"},{"key":"3876_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101460","author":"W Luo","year":"2025","unstructured":"Luo W, Guo L, Lu L, Huang N, Tao Y et al (2025) Preclinical studies of an AAV8-CYP4V2 gene therapy VGR-R01 for the treatment of Bietti crystalline dystrophy. Mol Ther Methods Clin Dev. https:\/\/doi.org\/10.1016\/j.omtm.2025.101460","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"2","key":"3876_CR68","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jamaophthalmol.2024.5619","volume":"143","author":"X Chen","year":"2025","unstructured":"Chen X, Liu X, Cui S, Wang G, Liu Y et al (2025) Safety and vision outcomes following gene therapy for Bietti crystalline dystrophy: a nonrandomized clinical trial. JAMA Ophthalmol 143(2):126\u2013133","journal-title":"JAMA Ophthalmol"},{"issue":"21","key":"3876_CR69","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","volume":"390","author":"EA Pierce","year":"2024","unstructured":"Pierce EA, Aleman TS, Jayasundera KT, Ashimatey BS, Kim K et al (2024) Gene editing for CEP290-associated retinal degeneration. N Engl J Med 390(21):1972\u20131984. https:\/\/doi.org\/10.1056\/NEJMoa2309915","journal-title":"N Engl J Med"},{"issue":"7","key":"3876_CR70","first-page":"3925","volume":"65","author":"W Zhou","year":"2024","unstructured":"Zhou W, Shen Y (2024) Novel gene therapy for XLRS: initial findings from a clinical trial showing visual improvement. Invest Ophthalmol Vis Sci 65(7):3925\u20133925","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3876_CR71","unstructured":"inc R (2025) AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program."},{"issue":"12","key":"3876_CR72","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1080\/17425247.2024.2435461","volume":"21","author":"TA Ciulla","year":"2024","unstructured":"Ciulla TA, Cunningham ET Jr. (2024) Suprachoroidal drug delivery: a versatile therapeutic platform. Expert Opin Drug Deliv 21(12):1705\u20131713. https:\/\/doi.org\/10.1080\/17425247.2024.2435461","journal-title":"Expert Opin Drug Deliv"},{"issue":"8","key":"3876_CR73","first-page":"1861","volume":"66","author":"C Kay","year":"2025","unstructured":"Kay C, Khanani AM, Hu A, Eichenbaum DA, Danzig C et al (2025) Interim results from the phase 2b population extension cohort in the PRISM clinical trial evaluating 4D\u2013150 in adults with neovascular (wet) age-related macular degeneration. Invest Ophthalmol Vis Sci 66(8):1861\u20131861","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3876_CR74","unstructured":"(2021) ADVM-022  offers sustained anatomic improvements in wet AMD."},{"issue":"7","key":"3876_CR75","first-page":"5338","volume":"65","author":"H Li","year":"2024","unstructured":"Li H, Shu Y, Xu D, Hou J (2024) SKG0106, an AAV vector delivered intravitreally, for effective, safe and durable treatment of nAMD. Invest Ophthalmol Vis Sci 65(7):5338\u20135338","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3876_CR76","first-page":"732","volume":"64","author":"EM Lad","year":"2023","unstructured":"Lad EM, Chao DL, Pepio A, Zhang W, Capuano G et al (2023) Pooled safety analysis of a single intravitreal injection of JNJ-1887 (gene therapy, AAVCAGsCD59) in patients with age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 64(8):732\u2013732","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3876_CR77","first-page":"4378","volume":"65","author":"Y Liu","year":"2024","unstructured":"Liu Y, Song M, Feng J, Li L, Wang F et al (2024) Subretinal LX102 gene therapy for neovascular age-related macular degeneration (nAMD): 1 year follow-up of an investigator initiated trial. Invest Ophthalmol Vis Sci 65(7):4378\u20134378","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3876_CR78","first-page":"6385","volume":"66","author":"S Huddleston","year":"2025","unstructured":"Huddleston S, Shearn SP, Oughton AM, Winters C, Zheng Q et al (2025) VAN-2201: phase 1 study of KH631 gene therapy for the treatment of wet AMD (NCT05657301). Invest Ophthalmol Vis Sci 66(8):6385\u20136385","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3876_CR79","first-page":"1916","volume":"64","author":"G Ye","year":"2023","unstructured":"Ye G, Shen J, Dai L, Formica R, Wang L et al (2023) Efficacy evaluation of EXG102-031, a novel AAV-based gene therapy for neovascular AMD in a mouse model of VEGF-A-induced exudative retinal detachment vascular leakage mouse model. Invest Ophthalmol Vis Sci 64(8):1916\u20131916","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3876_CR80","first-page":"4357","volume":"65","author":"A Luk","year":"2024","unstructured":"Luk A, Xing D, Liu B, Liu W, Zhang S et al (2024) World\u2019s first CRISPR\/RNA-targeting therapy (HG202) for patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 65(7):4357\u20134357","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3876_CR81","unstructured":"(2025) Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration."},{"key":"3876_CR82","unstructured":"(2025) EXPLORE A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (EXPLORE)."},{"key":"3876_CR83","doi-asserted-by":"crossref","unstructured":"Yanovitch L, Raz-Prag D, Hanein Y (2022) A new high-resolution three-dimensional retinal implant: system design and preliminary human results. BioRxiv: 2022.2009. 2014.507901","DOI":"10.1101\/2022.09.14.507901"},{"issue":"10","key":"3876_CR84","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.10.10.14","volume":"10","author":"H Xu","year":"2021","unstructured":"Xu H, Zhong X, Pang C, Zou J, Chen W et al (2021) First human results with the 256 channel intelligent micro implant eye (IMIE 256). Transl Vis Sci Technol 10(10):14. https:\/\/doi.org\/10.1167\/tvst.10.10.14","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"3876_CR85","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00417-014-2797-x","volume":"253","author":"VB Kitiratschky","year":"2015","unstructured":"Kitiratschky VB, Stingl K, Wilhelm B, Peters T, Besch D et al (2015) Safety evaluation of \u201cretina implant alpha IMS\u201d\u2013a prospective clinical trial. Graefes Arch Clin Exp Ophthalmol 253(3):381\u2013387. https:\/\/doi.org\/10.1007\/s00417-014-2797-x","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1757","key":"3876_CR86","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.2013.0077","volume":"280","author":"K Stingl","year":"2013","unstructured":"Stingl K, Bartz-Schmidt KU, Besch D, Braun A, Bruckmann A et al (2013) Artificial vision with wirelessly powered subretinal electronic implant alpha-IMS. Proc Biol Sci 280(1757):20130077. https:\/\/doi.org\/10.1098\/rspb.2013.0077","journal-title":"Proc Biol Sci"},{"key":"3876_CR87","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fnins.2017.00445","volume":"11","author":"K Stingl","year":"2017","unstructured":"Stingl K, Schippert R, Bartz-Schmidt KU, Besch D, Cottriall CL et al (2017) Interim results of a multicenter trial with the new electronic subretinal implant Alpha AMS in 15 patients blind from inherited retinal degenerations. Front Neurosci 11:445. https:\/\/doi.org\/10.3389\/fnins.2017.00445","journal-title":"Front Neurosci"},{"issue":"8","key":"3876_CR88","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ophtha.2020.02.024","volume":"127","author":"D Palanker","year":"2020","unstructured":"Palanker D, Le Mer Y, Mohand-Said S, Muqit M, Sahel JA (2020) Photovoltaic restoration of central vision in atrophic age-related macular degeneration. Ophthalmology 127(8):1097\u20131104. https:\/\/doi.org\/10.1016\/j.ophtha.2020.02.024","journal-title":"Ophthalmology"},{"issue":"1","key":"3876_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-024-00408-y","volume":"11","author":"JL Ali\u00f3","year":"2024","unstructured":"Ali\u00f3 JL, Mart\u00ednez-Abad A, Ruiz-Mesa R, Kim HM, Mendicute J et al (2024) Visual and patient reported outcomes provided by a refractive multifocal intraocular lens based on continuous transitional focus. Eye Vis Lond 11(1):41. https:\/\/doi.org\/10.1186\/s40662-024-00408-y","journal-title":"Eye Vis Lond"},{"key":"3876_CR90","unstructured":"Iridium Medical Technologies (2025) HARP4k\u2019s Retinal Prosthesis System Next GeneratioN Retinal Prosthesis."},{"issue":"12","key":"3876_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115239","volume":"9","author":"LN Ayton","year":"2014","unstructured":"Ayton LN, Blamey PJ, Guymer RH, Luu CD, Nayagam DA et al (2014) First-in-human trial of a novel suprachoroidal retinal prosthesis. PLoS ONE 9(12):e115239. https:\/\/doi.org\/10.1371\/journal.pone.0115239","journal-title":"PLoS ONE"},{"key":"3876_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121191","volume":"279","author":"SC Eggenberger","year":"2021","unstructured":"Eggenberger SC, James NL, Ho C, Eamegdool SS, Tatarinoff V et al (2021) Implantation and long-term assessment of the stability and biocompatibility of a novel 98 channel suprachoroidal visual prosthesis in sheep. Biomaterials 279:121191. https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121191","journal-title":"Biomaterials"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03876-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03876-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03876-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:11:23Z","timestamp":1765779083000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03876-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3876"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03876-w","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"21"}}